ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, cilt.24, sa.4, ss.585-593, 2015 (SCI-Expanded)
Background. Cisplatin, an effective chemotherapeutic agent, is used for the treatment of several types of cancers. However, cisplatin has some severe side effects such as nephrotoxicity. On the other hand, molsidomine, a NO donor, has anti-oxidative and vasodilator effects.